OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals
Samuel R. Chamberlain, Karin Mogg, Brendan P. Bradley, et al.
Psychopharmacology (2012) Vol. 224, Iss. 4, pp. 501-509
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology
Liana R. N. Schreiber, Brian L. Odlaug, Jon E. Grant
Journal of Behavioral Addictions (2013) Vol. 2, Iss. 4, pp. 191-198
Open Access | Times Cited: 108

Pathological Overeating: Emerging Evidence for a Compulsivity Construct
Catherine F. Moore, Valentina Sabino, George F. Koob, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 7, pp. 1375-1389
Open Access | Times Cited: 106

Endogenous opiates and behavior: 2012
Richard J. Bodnar
Peptides (2013) Vol. 50, pp. 55-95
Closed Access | Times Cited: 94

Neurobiological features of binge eating disorder
Iris M. Balodis, Carlos M. Grilo, Marc N. Potenza
CNS Spectrums (2015) Vol. 20, Iss. 6, pp. 557-565
Open Access | Times Cited: 67

Cognitive biases in binge eating disorder: the hijacking of decision making
Valerie Voon
CNS Spectrums (2015) Vol. 20, Iss. 6, pp. 566-573
Open Access | Times Cited: 65

Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review
Sarah-Catherine Rodan, Emma Bryant, Anvi Le, et al.
Journal of Eating Disorders (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 19

Binge-eating disorder: Clinical and therapeutic advances
Peter H. Hutson, Iris M. Balodis, Marc N. Potenza
Pharmacology & Therapeutics (2017) Vol. 182, pp. 15-27
Closed Access | Times Cited: 54

A systematic and methodological review of attentional biases in eating disorders: Food, body, and perfectionism
Christina Ralph‐Nearman, Margaret Achee, Rachel C. Lapidus, et al.
Brain and Behavior (2019) Vol. 9, Iss. 12
Open Access | Times Cited: 49

A placebo‐controlled pilot study of the novel opioid receptor antagonist ALKS‐33 in binge eating disorder
Susan L. McElroy, Anna I. Guerdjikova, Thomas J. Blom, et al.
International Journal of Eating Disorders (2013) Vol. 46, Iss. 3, pp. 239-245
Open Access | Times Cited: 46

Attentional bias to food cues in youth with loss of control eating
Lisa M. Shank, Marian Tanofsky‐Kraff, Eric E. Nelson, et al.
Appetite (2014) Vol. 87, pp. 68-75
Open Access | Times Cited: 42

Neuropharmacology of compulsive eating
Catherine F. Moore, Julia I. Panciera, Valentina Sabino, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2018) Vol. 373, Iss. 1742, pp. 20170024-20170024
Open Access | Times Cited: 31

The role of the opioid system in binge eating disorder
Chiara Giuliano, Pietro Cottone
CNS Spectrums (2015) Vol. 20, Iss. 6, pp. 537-545
Open Access | Times Cited: 30

Pharmacotherapy of Obesity: Limits and Perspectives
Pamela Rosa-Gonçalves, David Majerowicz
American Journal of Cardiovascular Drugs (2019) Vol. 19, Iss. 4, pp. 349-364
Closed Access | Times Cited: 22

Opioid modulation of cognitive impairment in depression
Moriah L. Jacobson, Hildegard A. Wulf, Caroline A. Browne, et al.
Progress in brain research (2018), pp. 1-48
Open Access | Times Cited: 21

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
Hisham Ziauddeen, Liam J. Nestor, Naresh Subramaniam, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 11, pp. 2647-2657
Open Access | Times Cited: 16

The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu‐opioid receptor antagonist GSK1521498 in healthy subjects
Hisham Ziauddeen, Pradeep J. Nathan, Chris Dodds, et al.
The Journal of Clinical Pharmacology (2013) Vol. 53, Iss. 10, pp. 1078-1090
Open Access | Times Cited: 12

Central nervous system biomarkers for antiobesity drug development
Hisham Ziauddeen, Paul C. Fletcher
Drug Discovery Today (2013) Vol. 18, Iss. 23-24, pp. 1282-1291
Open Access | Times Cited: 10

Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys
Vanessa Minervini, Alex Disney, Stephen M. Husbands, et al.
Psychopharmacology (2020) Vol. 237, Iss. 10, pp. 3057-3065
Open Access | Times Cited: 10

Acute alcohol does not impair attentional inhibition as measured with Stroop interference scores but impairs Stroop performance
Philipp Riedel, Max Wolff, Maik Spreer, et al.
Psychopharmacology (2021) Vol. 238, Iss. 6, pp. 1593-1607
Open Access | Times Cited: 8

Dissecting compulsive eating behavior into three elements
Catherine F. Moore, Valentina Sabino, George F. Koob, et al.
Elsevier eBooks (2019), pp. 41-81
Closed Access | Times Cited: 4

Impacts of endogenous opioid blockade and sex on working memory among ad libitum and abstinent smokers and non-smokers
Ryan Johnson, Briana N. DeAngelis, Motohiro Nakajima, et al.
Addiction Neuroscience (2024), pp. 100177-100177
Open Access

Usos terapéuticos potenciales de los antagonistas opioides: Fisiopatología y evidencia preclínica
Mauricio O. Nava-Mesa, Angélica María Téllez-Arévalo, Daniel Rojas-Kozhakin, et al.
Revista Colombiana de Ciencias Químico Farmacéuticas (2015) Vol. 44, Iss. 3, pp. 322-358
Open Access | Times Cited: 1

Beyond substance use disorders
Justin R. Yates
Elsevier eBooks (2023), pp. 531-570
Closed Access

Central and Peripheral Biomarkers for the Study of Appetite Regulation in Humans
Juan José Hernández Morante, Carlos Martínez
Biomarkers in disease (2022), pp. 1-26
Closed Access

Page 1 - Next Page

Scroll to top